electroCore Names Co-CEOs Lev and Fox to Drive Next-Growth Phase…

Event summary

electroCore appoints Joshua Lev and Mike Fox as Co-CEOs effective September 8, 2026.
Lev, previously Interim President and CFO, retains financial and R&D oversight.
Fox, former COO, leads commercial operations including sales and marketing.
Board cites complementary strengths and collaborative leadership as key to decision.

The big picture

The co-CEO model reflects a growing trend in bioelectronic medicine companies to blend operational and financial expertise during scaling phases. electroCore's move underscores the challenge of balancing innovation pipelines with commercial execution in a competitive medical device market. The appointment comes as the company targets expanded indications and revenue growth across its non-invasive neuromodulation portfolio.

What we're watching

Dual Leadership Dynamics: How the co-CEO structure will impact decision velocity and strategic consistency.
Commercial Acceleration: Whether Fox's market development focus can expand prescription and wellness revenue streams.
EBITDA Timeline: The pace at which the company achieves positive adjusted EBITDA under shared leadership.